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Background: The Revised Illness Perception Questionnaire (IPQ-R) has been used extensively in the study of illness
perceptions across different populations. Only few confirmatory factor analytic (CFA) studies of the questionnaire
are available. This study examines the construct and discriminant validity of the Turkish IPQ-R in patients with
diabetes and cardiovascular disease focusing on the hypothesized seven dimensions of personal controllability,
treatment controllability, timeline acute/chronic, timeline cyclical, coherence, consequences and emotional
representations.
Methods: 302 patients (60.6% women) with a medically confirmed diagnosis of diabetes or cardiovascular disease
and a mean age of 53.9 years were recruited from out-patient clinics in Turkey and surveyed by means of
standardized interviews. Direct maximum likelihood confirmatory factor analysis was conducted.
Results: Several areas of ill-fit were identified in the original measurement model of the IPQ-R. Four items
(items 17, 19, 20, and 31) were deleted because of poor factor loadings. Also, two error covariances (between
items 33 and 34 and between items 7 and 8) were added and item 6 respecified to obtain a good model fit.
The modified 34-item model showed good reliability and discriminant validity.
Conclusion: In accordance with studies on other language adaptations of the questionnaire, we identified certain
items of the IPQ-R as potential sources of poor model fit. Their inclusion should be reconsidered in future
applications of the questionnaire and researchers should examine whether our reduced set of items is stable across
different populations. Our modified 34-item model showed a good reliability and discriminant validity and hence
could be a valuable instrument in the assessment of illness perceptions in the Turkish health care setting, provided
that the model is confirmed in subsequent research.
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Chronic diseases such as diabetes and cardiovascular
disease evolve gradually. They usually require long-term
therapies and have consequences on the everyday life of
affected individuals [1]. In the study of patients’ coping
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reproduction in any medium, provided the orself-regulatory model of illness (SRM) developed by
Leventhal, Meyer & Nerenez has gained particular atten-
tion [2]. It suggests that individuals develop perceptions
of their illness that have an impact on the choice and ap-
praisal of coping strategies—and both illness perceptions
and coping strategies are constantly adjusted to one an-
other throughout the course of illness [2]. Leventhal
et al. identified five core dimensions of cognitive illness
perceptions: identity (perceptions about symptoms and
illness labels), consequences (beliefs about possible illnessLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ness), cause (beliefs about the cause of the illness) and
cure/control (beliefs about controllability and curability
of the illness) [3]. These cognitive perceptions are ac-
companied by the development of emotional representa-
tions such as fear of illness severity.
The assumptions of the model are supported by em-
pirical research. In a meta-analysis Hagger & Orbell illu-
strated that illness perceptions are associated with
physical functioning, psychological distress, role func-
tioning, social functioning, vitality, psychological well-
being and health-related quality of life [4]. Also, there is
some evidence that health outcomes and quality of care
can be significantly improved when illness perceptions
of patients are addressed in the health care process [5].
Among the quantitative instruments for the assess-
ment of illness perceptions [6], the Illness Perception
Questionnaire has gained most acceptance. It was ori-
ginally developed by Weinman et al. [7] and was revised
by Moss-Morris et al. [8] to improve its psychometric
performance. Today the Revised Illness Perception
Questionnaire (IPQ-R) is the most commonly used in-
strument for the assessment of illness perceptions. It is
theoretically derived from the SRM with the dimensions
of the SRM each being represented by a scale consisting
of several items. In the course of the development of the
IPQ-R, the control and timeline dimensions were further
differentiated and each split into two scales. The per-
sonal control scale represents beliefs about personal abil-
ities to control illness and the treatment control scale
represents beliefs about the ability of the treatment or
therapy to control or cure illness. Similarly, the timeline
acute/chronic scale assesses beliefs about the duration of
illness, while the timeline cyclical scale assesses beliefs
about stability of illness symptoms over time. Moss-
Morris et al. also introduced the coherence scale in order
to measure the degree to which the individual considers
his or her illness as comprehensive and clear [8].
Based on its layout and response format, the IPQ-R
can be divided into three parts: Part I examining illness
identity by means of 14 items with a double yes-no re-
sponse format, part II assessing the seven dimensions of
controllability (personal and treatment), timeline (acute/
chronic and cyclical), coherence, emotional representa-
tions and consequences by means of 38 items with a 5-
point Likert scale response format (strongly agree to
strongly disagree), and part III applying the same re-
sponse format and presenting 18 items on causal
attributions.
Moss-Morris et al. [8] tested the validity and reliability
of the IPQ-R in patients from eight different illness
groups. It showed a good test-retest reliability and good
divergent, known group and predictive validity. Explora-
tory analyses by means of principal component analysissupported the construct validity of the seven factor
model of the IPQ-R part II.
Several translations of the instrument into other lan-
guages are available on the internet (http://www.uib.no/
ipq). The Turkish version of the IPQ-R was evaluated
exploratively by means of principal component analysis
in patients with cancer and other physical diseases ad-
mitted to hospitals in Istanbul, Turkey [9]. It showed
properties similar to the original version. Despite the ex-
tensive use of the IPQ-R in health research and practice,
only few studies evaluated its factor structure by means
of a hypothesis-testing approach. Confirmatory factor
analysis (CFA), for example, is considered superior to
data-driven procedures such as principal component
and exploratory factor analysis. It allows to test for a fac-
tor structure that is hypothesized by theory and is
powerful in exploring potential areas of ill-fit. These
advantages are particularly important when researchers
aim to examine the transferability of instruments across
different populations and languages [10]. Aside from
studies that aimed to confirm the validity of the IPQ-R
applied to English speaking populations [11-16], to our
knowledge only three CFA studies evaluated the factor
structure of translated versions of the seven-dimensional
core part of the IPQ-R (part II)—the Chinese [17], the
Swedish [18] and an adapted Spanish version of the
questionnaire [19]. All three CFA studies identified con-
siderable sources of ill-fit in the measurement model
proposed by Moss-Morris et al. [8] and several modifica-
tions had to be applied to obtain good model fit in the
populations under study. These results illustrate that a
thorough evaluation of the instrument’s construct valid-
ity is necessary before it can be applied in research on
illness perceptions.
The aim of our study was to examine the factor struc-
ture of the Turkish IPQ-R and to test the measurement
model proposed by Moss-Morris et al. [8] in Turkish
patients with diabetes and cardiovascular disease by
means of CFA. In line with previous research, we fo-
cused on the 38 items of the seven-dimensional IPQ-R
part II.
Methods
Study design and data collection procedures
We recruited patients with a medically confirmed diag-
nosis of diabetes or cardiovascular disease (hypertensive
disease, ischemic and pulmonary heart disease) from
out-patient clinics in Gaziantep, Turkey during August
2010 and June 2011. Overall 314 patients were
approached of which 302 (96.2%) participated in the
study. Patients were surveyed by means of a quantitative
questionnaire (see below) during their stay in the clinic
using standardized interviews. They were informed
about the purpose of the study and about the voluntary
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lysis procedure. Prior to the survey, all participants gave
consent to their participation. The study was cleared by
the appropriate ethics committee at the University of
Münster, Germany.
Measures
The Turkish version of the Revised Illness Perception
Questionnaire (part II) was administered as translated
and published by Kocaman et al. [9] and Armay et al.
[20]. The authors translated the questionnaire using a
forward-backward translation by two independent
researchers following guidelines of cross-cultural adapta-
tion. It was pilot-tested in a clinical setting in Istanbul.
In the present study, the original 5-point Likert scale re-
sponse format was retained. Aside from the IPQ-R, the
research instrument included questions on the duration
of illness and on basic socio-demographic information
such as age, sex and level of education.
Sample size considerations
Given a number of ≥3 indicators per latent variable of
the IPQ-R part II, a sample size of 300 can be consid-
ered sufficient for confirmatory factor analysis [21]. This
was further supported by a Monte Carlo study with a
simulated amount of 5% missing values conducted fol-
lowing published guidelines [22]. Population values for
parameter estimates were obtained from prior research
[9,12]. With a sample size of 300, parameter and stand-
ard error biases did not exceed the recommended
threshold of 10%, coverage was between 93% and 97%
and average values for goodness-of-fit indices indicated
good model fit [22].
Statistical analysis
Measures of central tendency, frequencies, chi-square-
tests and independent t-tests were used for sample
description.
Direct maximum likelihood (ML) confirmatory factor
analysis (CFA) was used to examine the construct valid-
ity of the 38 items of the Turkish IPQ-R part II [10].
CFA was conducted using Mplus version 5.1 [23]. The
hypothesized factor structure of the IPQ-R part II tested
was the standard seven-factor solution identified by
Moss-Morris et al. [8]. It consists of the timeline acute/
chronic (items 1–5, 18), consequences (items 6–11), per-
sonal control (items 12–17), treatment control (items
19–23), illness coherence (item 24–28), timeline cyclical
(items 29–32) and emotional representations (items 33–
38) factor. The factors were allowed to covary.
The fit of the measurement model was assessed by dif-
ferent fit indices. The goodness-of-fit chi-square and the
standardized root mean square residual (SRMR) were
calculated as indices of absolute model fit. SRMR values≤0.08 were considered to indicate acceptable model fit.
The comparative fit index (CFI) and the Tucker-Lewis
index (TLI) were used to evaluate the adequacy of the
proposed CFA model in comparison to a restricted inde-
pendence model. According to guidelines, CFI and TLI
values >0.90 indicate a good fit of the CFA model. Also,
the root mean square error of approximation (RMSEA)
and its 90%-confidence interval were calculated with
RMSEA values between 0.05 and 0.08 considered indi-
cating a reasonable and values <0.05 considered indicat-
ing a good model fit [10,24].
The reliability was assessed by composite reliability
estimates (ρ) with values ≥0.60 indicating satisfactory re-
liability in the latent factors [25]. Discriminant validity of
the seven factors was evaluated by the size of their inter-
correlations with correlation coefficients <0.85 indicating
acceptable discriminant validity [24].
Items with completely standardized factor loadings (λ)
<0.40 and standardized residuals >2.58 were considered
for deletion. Furthermore, modification indices (MI) and
completely standardized expected parameter changes
(EPC) were calculated in order to identify potential for
model improvement. Only modifications reasonable on
theoretical grounds were made and implemented one-
by-one as suggested by published guidelines [10].
A maximum of 3.8% missing values was observed for
the IPQ-R items in the sample. To prevent selection
bias, direct ML estimation was used for CFA as recom-
mended by Brown [10].
Results
Sample description
302 patients with diabetes and/or cardiovascular disease
participated in the study. Of these, 183 (60.6%) were fe-
male. On average, patients were 53.9 years old, with a
mean duration of illness treatment of 8.8 years. Men had
a significantly higher educational status than women,
with 8.5% of men as compared to 37.4% of women hav-
ing no formal school education (p < 0.001). 62.1% of all
patients reported to have diabetes, 20.6% stated to have
cardiovascular disease and 17.3% reported both condi-
tions. These proportions slightly differed between men
and women (p < 0.05). Basic characteristics of the study
sample stratified by sex are displayed in Table 1.
Confirmatory factor analysis
The original factor structure proposed by Moss-Morris
et al. [8] did not fit the data well as indicated by several
goodness-of-fit measures. Although RMSEA indicated a
reasonable fit (RMSEA= 0.075 [90%-CI = 0.070-0.079]),
the other fit indices were below the thresholds for ac-
ceptable fit (χ2 = 2396.73 [df = 644,p < 0.001]; SRMR=
0.109; TLI = 0.765; CFI = 0.785; AIC= 18177.43). Four
items showed low and non-significant factor loadings.
Table 1 Basic characteristics of the sample stratified by
sex
Sex Total
(n = 302)Male
(n = 119)
Female
(n = 183)
Age in years (mean; sd)
(p > .05)
55.4; 11.8 52.9; 10.9 53.9; 11.3
Education (%)(p < .001)
no school education 8.5 37.4 26.1
primary school education 47.9 41.2 43.8
secondary school education 11.1 5.5 7.7
high school or university
education
32.5 15.9 22.4
Diseases (%) (p < .05)
Diabetes 58.5 64.5 62.1
Cardiovascular disease 27.1 16.4 20.6
Diabetes and cardiovascular
disease
14.4 19.1 17.3
Duration of disease treatment
in years (mean; sd) (p > .05)
8.9; 6.6 8.7; 6.7 8.8; 6.6
sd: standard deviation.
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(item 17 “My actions will have no effect on the outcome
of my illness”, λ=0.11), the second and third were part of
the treatment control factor (item 19 “There is little I
can do to control my illness”, λ=0.10; item 20 “Treat-
ment will be effective in treating my illness”, λ=0.19) and
the fourth was specified to load on the timeline cyclical
factor (item 31 “My illness is very unpredictable”,
λ=0.21). All other factor loadings were significant and
ranged from 0.40 to 0.90. All standardized residuals were
<2.58.
For a modified model (model 2a), we dropped the
above mentioned items with poor loadings and con-
ducted CFA on the remaining 34 items. Goodness-of-
fit indices suggested an improvement of the model fitTable 2 Goodness-of-fit indices for the original and revised m
Model χ2 (df) Δχ
Model 1 (M1): Original (38 items) 2396.73
(644)*
Model 2a (M2a): Modified (34 items) 1479.46 M1
(506)* 91
Model 2b (M2b): Modified (34 items, 2 error covariances) 1261.09 M2
(504)* 21
Model 2c (M2c): Modified (34 items, 2 error covariances,
item 6 respecified)
1150.39 M2
(504)* 11
Note. χ2 (df): chi-square test of model fit and degrees of freedom; RMSEA (90%-CI): r
standardized root mean square residual; CFI: comparative fit index; TLI: Tucker-Lewias compared to the initial model (χ2 = 1479.46 [df =
506,p < 0.001]; RMSEA= 0.059 [90%-CI = 0.054-0.064];
SRMR= 0.083; TLI = 0.864; CFI = 0.877; AIC= 15404.43).
However, fit indices were still not within levels that indi-
cate acceptable fit. Also, modification indices (MI) and
completely standardized expected parameter changes
(EPC) suggested that relevant modifications could be
made in the model. As these modifications were theoret-
ically sound they were carried out in a second modified
model (model 2b) and implemented one-by-one. The
two largest modification indices suggested to add error
covariances between items 33 (“I get depressed when I
think about my illness”) and 34 (“When I think about my
illness I get upset”) belonging to the emotional represen-
tations factor (MI = 109.571; EPC= 0.158) as well as be-
tween items 7 (“My illness has major consequences on
my life”) and 8 (“My illness does not have much effect on
my life”) belonging to the consequences factor (MI =
80.522; EPC= 0.845). The respecified model resulted in a
considerably better fit (χ2 = 1261.09 [df = 504,p < 0.001];
RMSEA= 0.050 [90%-CI = 0.045-0.056]; SRMR= 0.079;
TLI = 0.901; CFI = 0.911; AIC= 15189.58). Finally, MI and
EPC suggested to respecify item 6 (“My illness is a ser-
ious condition”) to load on the timeline acute/chronic
factor (MI = 72.503; EPC= 0.690). The revised final
model (model 2c) with 34 indicators and two error covar-
iances resulted in good fit suggesting superiority to the
other three models (χ2 = 1150.39 [df = 504,p < 0.001];
RMSEA= 0.045 [90%-CI = 0.039-0.050]; SRMR= 0.067;
TLI = 0.921; CFI = 0.929; AIC = 15079.40). A detailed
overview of the goodness-of-fit indices for the four mod-
els is presented in Table 2.
Table 3 shows completely standardized factor loadings,
standard errors and composite reliabilities for the
revised final model (model 2c). All factors were statisti-
cally significant and composite reliability estimates
exceeded the recommended threshold of 0.60, indicating
satisfactory reliability in the latent factors.odels of the Turkish IPQ-R part II (n = 302)
2 (Δdf) RMSEA
(90%-CI)
SRMR TLI CFI AIC
0.075 0.109 0.765 0.785 18177.43
(0.070-0.079)
-M2a: 0.059 0.083 0.864 0.877 15404.43
7.27 (138)* (0.054-0.064)
a-M2b: 0.050 0.079 0.901 0.911 15189.58
8.37 (2)* (0.045-0.056)
b-M2c: 0.045 0.067 0.921 0.929 15079.40
0.70 (0) (0.039-0.050)
oot mean square error of approximation and 90%-confidence intervals; SRMR:
s index: AIC: Akaike Information Criterion; *p < 0.001.
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IPQ-R part II are given in Table 4. No intercorrelation
exceeded the threshold of 0.85, suggesting acceptable dis-
criminant validity. The largest correlations were observed
between the treatment and personal control factor
(r = 0.54), between the consequences and emotional
representations factor (r = 0.46) and between the timeline
acute/chronic and consequences factor (r = 0.36).Discussion
The aim of our study was to formally assess the factor
structure of the Turkish IPQ-R and to rigorously test the
measurement model proposed by Moss-Morris et al.
(2002) [8] in Turkish patients with diabetes and cardiovas-
cular disease residing in Turkey. Aside from this study,
only three other studies have examined the dimensional
structure of non-English language versions of the IPQ-R
by means of a hypothesis-testing framework. The original
structure of the second part of the IPQ-R could not be
confirmed for the population in our study. While the
emotional representations and illness coherence factor
showed satisfactory construct validity, several modifica-
tions had to be applied to the other factors to achieve a
good model fit. A poor fit of the original measurement
model was also observed in other CFA studies. This com-
prises an evaluation of the Chinese IPQ-R applied to
hypertensive patients in Taiwan [17], an evaluation of the
Swedish IPQ-R applied to patients recovering from myo-
cardial infarction [18] as well as several CFA studies on
the English version of the instrument applied to patients
with different chronic diseases [11-13,15,16], including a
recent study on populations of African origin with type 2
diabetes [14]. In these studies, several areas of ill-fit were
identified and substantial changes to the measurement
model such as the deletion of items and the respecification
of indicators had to be applied to achieve acceptable
model fit.
In our study, items purported to load on the personal
control, treatment control and timeline cyclical factor
had to be deleted from further analysis due to low factor
loadings. Two of these four items (17 and 19) are nega-
tively worded and, for the same reason, were also
dropped from the analysis in the studies by Chen et al.
[17] on the Chinese and Cabassa et al. [19] on a shor-
tened 27-item Spanish version of the IPQ-R. Though
retained in the model, item 17 also showed a low factor
loading (standardized λ=0.25) in the Swedish validation
study of the IPQ-R [18]. Item 19 was also deleted by
Abubakari et al. [14] in their study of the IPQ-R in type 2
diabetes patients of African origin because of a low load-
ing on its respective factor. The problems encountered
with these two items may be due to a method bias. It is
known from scale development research that negativelyworded items may introduce method effects because they
can be misunderstood by respondents [26].
Similar to our study, item 20 was also considered
problematic by Abubakari et al. [14]. Based on consulta-
tions with subjects from their study population, the
authors argue that this may be due to a mismatch be-
tween own beliefs of the patients (that are also shaped
by supernatural causal attributions) and information
they receive from others (e.g. doctors). This may be also
true for Turkish patients who have been reported to
have strong beliefs in fate and divine influence [27,28].
The four items (17, 19, 20, 31) deleted in our study
should be thoroughly scrutinized in further applications of
the Turkish IPQ-R and their omission should be consid-
ered. Researchers should also thoroughly evaluate the reli-
ability of the timeline cyclical and treatment control
factor. Though still above the threshold that indicates ac-
ceptable reliability, the composite reliability of both factors
was lower than for the other five factors of the model.
Modifications indices strongly suggested to add two
error covariances between items 7 and 8 and between
items 33 and 34, indicating that these item pairs shared
measurement error. Similar to the reversed coding of
items 17 and 19, the error covariance between items 7
and 8 may result from the negative wording used in item
8. The error covariance between items 33 and 34 most
likely results from a very similar phrasing (see Table 3)
which in the Turkish version only differs by a weakly
discriminating adjective (“Hastalığımı düşündüğüm
zaman çökkün oluyorum” vs. “Hastalığımı düşündüğüm
zaman üzgün oluyorum”). In addition, unlike üzgün the
word çökkün is rather rarely used in the Turkish lan-
guage which bears potential for additional bias.
We recommend an alternative wording for item 33 such
as “Hastalığımı düşündüğüm zaman bunalıyorum” or
“Hastalığımı düşündüğüm zaman karamsar oluyorum”
(likewise literally meaning “When I think about my illness
I get depressed“) that may be better able to discriminate
and achieve equivalence with the original questionnaire.
In our study, item 6—originally purported to load on
the consequence factor—was related to the timeline
acute/chronic factor. Presumably this is because of the
item’s wording used in the Turkish version (“Ciddi bir
hastalığım var”). Although the adjective ciddi means
“serious”, it is often associated with chronicity in the
context of illness. The adjective ağır (severe, serious)
may be better able to attain semantic equivalence with
the original version and should be tested in future eva-
luations of the Turkish version.
The intercorrelations observed between the factors of
the revised final model support the discriminant validity
of the latent dimensions and are mostly in accordance
with those reported in other studies on the IPQ-R
[8,12,14,17,18]. The largest correlations indicated that
Table 3 Results of confirmatory factor analysis of the modified final measurement model (Model 2c: 34 items, 2 error
covariances, item 6 respecified) of the Turkish IPQ-R part II
Factors and items λ SE ρ
Timeline acute/chronic 0.92
1: My illness will last a short time 0.92** 0.03
2: My illness is likely to be permanent rather than temporary 0.95** 0.02
3: My illness will last a long time 0.96** 0.02
4: This illness will pass quickly 0.89** 0.04
5: I expect to have this illness for the rest of my life 0.96** 0.02
18: My illness will improve in time 0.76** 0.05
6: My illness is a serious condition 0.63** 0.06
Consequences 0.81
7: My illness has major consequences on my life 0.58** 0.06
8: My illness does not have much effect on my life 0.49** 0.06
9: My illness strongly affects the way other see me 0.61** 0.05
10: My illness has serious financial consequences 0.71** 0.05
11: My illness causes difficulties for those who are close to me 0.79** 0.04
Personal Control 0.82
12: There is a lot I can do to control my illness 0.57** 0.07
13: What I do can determine whether my illness gets better or worse 0.84** 0.05
14: The course of my illness depends on me 0.77** 0.07
15: Nothing I do will affect my illness 0.55** 0.09
16: I have the power to influence my illness 0.82** 0.06
Treatment Control 0.63
21: The negative effects of my illness can be prevented by my treatment 0.63** 0.18
22: Treatment can control my illness 0.56* 0.22
23: There is nothing that can help my illness 0.48** 0.14
Illness Coherence 0.91
24: The symptoms of my illness are puzzling to me 0.61** 0.06
25: My illness has no meaning to me 0.87** 0.03
26: I don’t understand my illness 0.90** 0.03
27: My illness doesn’t make any sense to me 0.90** 0.03
28: I have a clear picture or understanding of my illness 0.85** 0.04
Timeline cyclical 0.61
29: The symptoms of my illness change from day to day 0.49** 0.06
30: My symptoms come and go in cycles 0.63** 0.09
32: I go through cycles in which my illness gets better and worse 0.87** 0.09
Emotional representations 0.94
33: I get depressed when I think about my illness 0.88** 0.03
34: When I think about my illness I get upset 0.90** 0.02
35: My illness makes me feel angry 0.58** 0.05
36: My illness does not worry me 0.86** 0.03
37: My illness makes me feel anxious 0.95** 0.01
38: My illness makes me feel afraid 0.89** 0.02
Error covariance between items 33 and 34 0.69** 0.09
Error covariance between items 7 and 8 0.82** 0.04
Completely standardized factor loadings, standard errors, composite reliabilities and error covariances; n = 302; Note. λ: completely standardized factor loading; SE:
standard error; ρ: composite reliability; *p < 0.01, **p < 0.001.
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Table 4 Intercorrelations between the seven latent factors of the Turkish IPQ-R part II (n = 302)
Factors 1 2 3 4 5 6 7
1. Timeline acute/chronic
2. Consequences 0.36**
3. Personal control 0.29* 0.03
4. Treatment control 0.13 0.00 0.54*
5. Illness coherence 0.13 0.03 0.29* 0.10
6. Timeline cyclical 0.31* 0.24** 0.02 0.21 −0.08
7. Emotional representations 0.22** 0.46** −0.07 −0.10 −0.25** 0.25**
Note. *p < .01; **p < .001.
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hold stronger beliefs about personal abilities to control
their illness. Similarly, individuals viewing their illness as
a condition with serious consequences also show a more
intense emotional response to their illness. Both find-
ings are in line with assumptions of the self-regulatory
model [3].
The present study has limitations. First, our results
cannot be generalized to patients with diseases other
than diabetes and cardiovascular disease. Second, the
post hoc modifications of the model that we made
guided by modification indices and theoretical consid-
erations have to be considered an exploratory type of
analysis [10]. Thus, the changes we suggested are a start-
ing point for further analysis that should aim to cross-
validate and confirm the revised measurement model for
other populations. Third, we are aware that a sample
size of 300 is smaller than suggested by classical rules of
thumb that are usually guided by the ratio of subjects to
model parameters [25]. However, these recommenda-
tions have to be reconsidered in light of newer simula-
tion studies [21,29]. They show that characteristics such
as the number of indicators in the model, the number of
indicators per latent variable and the average size of fac-
tor loadings are of greater importance to attain precise
parameter estimates. Given the high factor loadings in
the present study (on average factor loadings in the
measurement model were ≥0.70) and a ratio of indica-
tors per latent variable of at least 3:1, the estimation in
the present study can be considered robust. In order to
further support the precision of our results we con-
ducted an additional Monte Carlo simulation using the
model estimates as population values following sugges-
tions by Brown [10]. The results showed that with the
given sample size and missing values proportion, the
percentage of parameter and standard error bias, the de-
gree of coverage and average values for goodness-of-fit
indices were within acceptable ranges [10,22].
Conclusion
Our study adds to current research on illness percep-
tions by providing a thorough examination of the factorstructure of the Turkish Revised Illness Perception
Questionnaire using confirmatory factor analysis. We
identified several misspecifications that contributed to a
poor model fit in the model proposed by the developers
of the original IPQ-R and—similar to studies on other
language adaptations of the questionnaire—some modifi-
cations had to be applied before a good model fit could
be achieved. We can confirm the observations made in
other studies on the IPQ-R that certain items are poten-
tial sources of ill-fit. The inclusion of these items should
be reconsidered in future applications of the instrument
and researchers should examine whether our reduced
set of items is stable across different populations. The
modifications we applied to the original measurement
model could serve as a starting point for further analysis.
In this respect, it must also be noted that despite the fact
that the Turkish translators of the IPQ-R used a rigorous
translation and adaptation procedure including pilot
testing [9,20], the translation remains rather literal and
applies standard rather than spoken language. Since both
aspects may reduce the questionnaire’s semantic equiva-
lence to the original version, we recommend that the
further evaluation of the Turkish IPQ-R also comprises
a qualitative component. For instance, this may include
a think-aloud survey on the understanding, interpret-
ation and usability of the questionnaire [30]. Similar sur-
veys were for example conducted on the Brief IPQ [31].
Our modified 34-item model showed a good reliability
and discriminant validity and hence could be a valuable
instrument in the assessment of illness perceptions in
the Turkish health care setting, provided that the model
is confirmed in subsequent research. Given the role of
illness perceptions in clinical practice, we therefore
strongly encourage further evaluation of the question-
naire in health research and practice. The IPQ-R may be
also useful in the study of illness perceptions among
Turkish migrant populations and could help to improve
health care for this population group in different host
countries. This could address findings from health ser-
vices research showing that Turkish migrant patients—
similar to other ethnic minority groups—experience
barriers to health care access and effectiveness that may
Brzoska et al. BMC Public Health 2012, 12:852 Page 8 of 8
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Prior to an application, however, a separate validation of
the IPQ-R in these populations is necessary [34].
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